SAN
DIEGO, April 11, 2023 /PRNewswire/
-- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine
technology innovation, focused on transforming spine surgery with
minimally disruptive, procedurally integrated solutions, today
announced its continued participation at various global conferences
throughout April and May.
"Our participation in spine conferences around the world
reflects our belief in partnering with the most influential
societies, study groups and congresses to advance spine care and
change patient lives," said Chris
Barry, chief executive officer at NuVasive. "We look forward
to showcasing our comprehensive, procedurally integrated
portfolios, our commitment to more intelligent surgery with the
Pulse platform, and the continued celebration of 20 years of
XLIF."
Learn about NuVasive's comprehensive 360 portfolios—X360, C360,
P360 and Complex—enabled by the Pulse platform. Procedural focuses
at each conference include:
- 52nd Annual Meeting of the Japanese Society for
Spinal Surgery and Related Research (JSSR): April 13–15 in
Sapporo, Japan, NuVasive will
celebrate XLIF and showcase the X360 portfolio.
- BritSpine 2023: April 18–20 in Scotland, United Kingdom, NuVasive will
feature the X360 and Complex portfolios enabled by Pulse at booth
#1.
- 2023 American Association of Neurological Surgeons (AANS)
Annual Scientific Meeting: April 21–23 in Los Angeles, NuVasive will celebrate XLIF,
feature all 360 portfolios and highlight the Spine Precision
Partnership with Siemens Healthineers at booth #1147.
- 2023 Pediatric Orthopaedic Society of North America (POSNA) Annual Meeting:
April 26–28 in Nashville, NuVasive
will feature its magnetically adjustable implant systems, Precice
and MAGEC at booth #603/703.
- SpineWeek 2023: May 1–5 in Melbourne, Australia, NuVasive will celebrate
XLIF and feature X360, C360 and Complex portfolios enabled by Pulse
at booth #C2.
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is the leader in spine technology
innovation, with a mission to transform surgery, advance care, and
change lives. The Company's less-invasive, procedurally integrated
surgical solutions are designed to deliver reproducible and
clinically proven outcomes. The Company's comprehensive procedural
portfolio includes surgical access instruments, spinal implants,
fixation systems, biologics, software for surgical planning,
navigation and imaging solutions, magnetically adjustable implant
systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements
included in this news release that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons and
hospitals, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available at
www.sec.gov. NuVasive assumes no obligation to update any
forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-participate-in-upcoming-global-spine-conferences-301793872.html
SOURCE NuVasive, Inc.